RetiSpec company

RetiSpec is developing a non-invasive eye scanner for early detection of Alzheimer’s Disease pathology years before symptoms occur, so that clinicians can intervene with emerging therapeutics early, when there’s a chance of actually impacting the disease.
Technology: P4 Medicine
Industry: Health Care
Headquarters: Toronto, Ontario, Canada
Founded Date: 2016-01-01
Employees Number: 1-10
Investors Number: 2
Last Funding Type: Seed

Visit Website
hello@retispec.com
Register and Claim Ownership